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Abstract 
Objective 
To explore stakeholder perspectives upon participant retention in clinical trials, and to generate 
strategies to support retention in a surgical, clinical trial. 
 
Study Design & Setting 
The SWIFFT trial is a multi-centre study comparing treatments for the fracture of the waist of the 
scaphoid bone in adults. Here we report upon a multi-stage, iterative consultative process with 
SWIFFT stakeholders, these include workshops with members of the public, with nurses involved in 
data collection, and with consultant clinicians. Structured discussions were digitally recorded and 
transcribed, data were handled and analysed following a framework approach to qualitative data 
analysis. 
 
Results 
Removing practical barriers were identified as important factors in supporting retention. Stakeholders 
also identified that i) how well a study is understood and ii) how much it is valued are important 
ĨĂĐƚŽƌƐŝŶĂŶŝŶĚŝǀŝĚƵĂů ?ƐǁŝůůŝŶŐŶĞƐƐƚŽŵĂŝŶƚĂŝŶƚŚĞŝƌŝŶǀŽůǀĞŵĞŶƚ ? A number of strategies resulted 
from this consultation, these include: in-clinic data collection, co-ordinated clinical and research 
appointments, a SWIFFT website and newsletter.  
 
Conclusion 
A participatory approach to trial retention might engage all relevant stakeholders in the delivery of a 
clinical trial, it might also support the generation of specific and contextually relevant solutions to the 
challenge of participant retention.  
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1. Background. 
 
Difficulties in recruitment and retention as barriers to the successful conduct of a clinical trial are well 
documented. Multiple systematic reviews illustrate challenges to trial recruitment and point to varied 
and complex reasons for this (1-8). Issues of retention, however, have received less explicit attention 
despite being equally problematic as it can introduce bias and challenge the validity of inference (9, 
10).  Reasons for attrition have commonly been considered alongside recruitment (11-13) and are 
similarly presented as complex and difficult to categorize. Where attrition has been considered in 
isolation, practical difficulties of maintaining contact with participants over an extended period, 
especially if they change address or telephone number, and participants losing interest or 
commitment, are highlighted (14).  
 
Evidence for the impact of strategies to support retention is uncertain, with limited systematic 
research focused upon retention strategies in clinical trials (12). Broader review, which include cohort 
and survey studies, point to the benefits of monetary incentives, teasers on envelopes, and recorded 
postal delivery (15), as well as reminder letters and shorter questionnaires (8).  Where review is 
restricted to randomised evaluations embedded within host clinical trials, most strategies to improve 
retention are targeted at questionnaire response rates for which monetary incentives (the offer of, 
adding monetary incentives and increasing monetary incentives) are shown to be effective (14). 
Evidence from single trials might also suggest that specialized postal strategies, recorded delivery and 
open-trial design may be beneficial (14). It is recognized that there has been limited consideration of 
strategies focused upon in-person data collection at, for example, hospital clinics (in contrast to postal 
questionnaires) and that investigation of such strategies is required (14).  
 
More general assessment suggests that trial context, research population and specific trial 
procedures significantly impact upon attrition (11, 16) and that qualitative investigation is important 
in the production of trial-specific retention strategies (11, 16). Elsewhere, others have pointed to the 
value of integrating qualitative research within clinical trials to further inform the research process 
(17, 18) and bodies such as INVOLVE (19, 20) and the James-Lind Alliance (www.lindalliance.org) point 
to the importance of engaging stakeholders in the generation, operation and management of clinical 
studies (21-25).  
 
A growing body of work demonstrates the value of engaging stakeholders in this way (26-30) and 
highlights how qualitative investigation might: expose specific misunderstandings about trial 
processes (31); illuminate local organizational cultures and norms (11); map distinctive characteristics 
(32, 33); identify important environmental factors (16); and, expose researcher attitudes which are 
impacting upon trial operation (34).  
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Here we consider a stakeholder-consultative process to inform retention strategies in the Scaphoid 
Waist internal Fracture Fixation Trial (SWIFFT) (http://www.nets.nihr.ac.uk/projects/hta/113637). 
This is a multi-centre trial comparing surgical fixation versus plaster cast treatment for fracture of the 
scaphoid bone in adults (35). It is a trial with multiple data collection points that include both 
completion of standard research instruments via post and return visits to hospital clinic for additional 
clinical assessment and imaging. The study primary end-point is 1-year, with an additional 5-year 
clinic review to establish long-term consequence of fracture and treatment. 
 
For SWIFFT, difficulties of retention may be exaggerated in two important ways. Previous review has 
identified that (amongst other characteristics) females are more likely to participate in research (36) 
and that younger people (amongst others) are more likely to drop out of research studies (37). The 
SWIFFT research population, most likely men under the age of the thirty, would seem vulnerable to 
both these trends. 
 
Here we report upon measures taken in the SWIFFT trial to generate strategies to support retention 
amongst the research population which could also be used to inform retention strategies in future 
studies. The purpose of this commentary is two-fold: to outline an approach to stakeholder 
consultation, and to describe the strategies and mechanisms that it generated. 
 
2. Methods.  
 
2.1 A multi-stage, iterative stakeholder consultation. 
To generate broader insight into issues of retention, and to generate strategies to support retention, 
a series of stakeholder consultations were held  W events took place over a six month period spanning 
the end of year 1 and beginning of year 2 in a 3 year programme of patient recruitment. Patients with 
a previous wrist/scaphoid fracture, research nurses and orthopaedic surgeons (all of whom were 
Principal Investigators on the SWIFFT Trial) participated in these events.   
 
An initial half-day workshop with members of the public explored how the trial is understood and 
perceived. Stakeholders were invited via mail-out to previous fracture clinic patients and via word of 
mouth recruitment in local clinic settings. Eight individuals volunteered to take part and all attended 
on the day; six (4 male, 2 female; all under 30 years old) had prior experience of a scaphoid fracture 
(all fully recovered), two had not experienced this fracture but were typical of the SWIFFT target 
population (i.e. male under 30). None of the individuals were currently eligible to participate in the 
SWIFFT trial. 
 
Short presentations about the study were made by members of the SWIFFT team and a structured 
discussion was led by PL and JD. Topics reflected a pragmatic concern for the successful operation of 
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the trial and included: whether the purpose and design of SWIFFT was well understood; the 
acceptability of data collection instruments; and, strategies to encourage participation and retention. 
Participants were encouraged to discuss these topics amongst themselves and to introduce issues, 
ideas and suggestions that they felt pertinent. Notes were made by participants and by facilitators 
during the workshop; discussion was also digitally audio recorded. Audio recordings were transcribed 
in full and hand-written notes captured digitally (for ease of handling) by both photographing sheets 
and transcribing content into Microsoft Word format. 
 
Research nurses at SWIFFT study sites were invited to a second half-day workshop; seventeen 
attended representing fourteen (of 26) different sites. PL, SB and JD facilitated the meeting 
introducing insight generated in the public meeting for discussion, once again participants were 
encouraged to discuss broadly and to raise additional topics and insight when relevant. Discussions 
were audio recorded and research nurses and facilitators invited to make notes during the workshop.  
Audio recordings were transcribed in full and again hand-written notes were digitized for ease of 
handling and analysis.  
 
A third strand of consultation focused upon SWIFFT principal investigators. SB and JD discussed 
retention at a sub-group meeting (SWIFFT PIs only) of a British Society for Surgery of the Hand (BSSH) 
event. Insights generated in the previous workshops were shared and discussion considered 
strategies which might be easily incorporated into normal routines. A short online survey covering 
similar topics was subsequently circulated to all principal investigators (n=26) via the Survey Monkey 
website. Online responses (n=17) and meeting notes were transferred to Microsoft Word.  
 
2.2 Analysis and development of the framework. 
ůůĚĂƚĂǁĞƌĞŚĂŶĚůĞĚƵƐŝŶŐE ?sŝǀŽ ? ? software package for qualitative data, and a framework 
approach was adopted in data analysis (38, 39).  PL led data analysis, generating and populating the 
analytic framework, with JD (primarily), SB and other members of the trial team verifying data 
interpretation and validating the form and content of the framework. 
 
Taking what is already known about trial retention (and to a lesser degree trial recruitment) as a 
starting point an initial analytic framework consisting of three broad themes was created. Data from 
the public workshop was then mapped to this framework and used to refine it - generating higher 
level codes within each theme by grouping lower level codes found in the data (see Table 1).  
 
Coding of data (transcripts and notes) was led by PL, with JD verifying the lower level coding, i.e. all 
data mapped to a specific lower level code would be reviewed to ensure coherence and consistency 
of coding. Where a lower level code incorporated inconsistent data (describing different factors or 
perspectives), data might be re-coded or the lower-level code revised or re-organised (e.g. with 
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distinct aspects disaggregated). The organization of lower level codes into higher level groupings 
(codes / sub-themes) was negotiated through discussion by the authors. Again all data organized 
within a higher level code would be reviewed to ensure coherence and consistency. Higher-level 
codes and analytic themes were presented to the SWIFFT trial management group as part of 
reporting progress. 
 
Insert Table 1: Initial analytic template. 
 
Data from subsequent phases of consultation were handled in a similar fashion: coded, organized 
within higher level codes, and situated within broader themes. At this point the framework might be 
amended or revised where new topics or different perspectives offered additional or different insight.  
 
2.3 Routine trial data monitoring. 
Strategies for improved retention generated from the stakeholder consultation were presented to the 
project oversight committees i.e. Trial Steering Committee (TSC) and Data Monitoring Ethics 
Committee (DMEC). Those that were subsequently approved by the Trial Management Group (TMG), 
and when necessary by the East Midlands (Derby) Research Ethics Committee (13/EM/0154), were 
incorporated into SWIFFT research procedures.  
 
3. Results.  
 
3.1 Multi-stage, iterative stakeholder consultation. 
Almost two hundred data points were coded to the initial analytic framework. The data was 
consistent in scope and tone across the different stakeholder groups with similar barriers to retention 
perceived and similar solutions offered. Almost half of those data points recorded addressed practical 
strategies to support involvement; additionally, barriers to participation and notional strategies to 
support involvement each covered around one-quarter of all data presented.  
 
Review of this data (by JD and PL) indicated that whilst practical solutions were perceived by 
stakeholders to be most important, other factors might be worthy of further investigation. Twenty-
eight (of 53) Barriers to Participation were coded as either Uncategorized or as linked to Perceptions 
of the study, leading to an assessment that less tangible factors might significantly affect retention 
rates. Data generated in the research nurse workshop reinforces this point - that participants might 
ĨĞĞůůŝŬĞ ?ŐƵŝŶĞĂƉŝŐƐ ? ?ŵŝŐŚƚŶŽƚĨƵůůǇƵŶĚĞƌƐƚĂŶĚƌĞƐĞĂƌĐŚƉƌŽĐĞƐƐĞƐ ?ŽƌŵŝŐŚƚǁĂŶƚƚŽĐĞĂƐĞ
participation as soon as they are well. These examples, with similar ones made by both members of 
ƚŚĞƉƵďůŝĐĂŶĚƚŚĞ^t/&&dW/Ɛ ?ƐƵŐŐĞƐƚƚŚĂƚĂƉĂƌƚŝĐŝƉĂŶƚƐ ?ĐŽŶĐĞƉƚƵĂůĞŶŐĂŐĞŵĞŶƚǁŝƚŚĂƐƚƵĚǇŝƐĂŶ
important factor in retention. 
 
8 
 
This assessment informed a revision of the analytic framework to one which more clearly 
disaggregates practical from less tangible barriers and connects the practical and notional benefits 
associated with a range of general and targeted strategies to improve retention (see Table 2). That 
practical measure might be perceived to encourage, as much as enable, participation points to a 
ďƌŽĂĚĞƌĐŽŶĐĞƌŶƚŚĂƚƌĞƚĞŶƚŝŽŶƐƚƌĂƚĞŐŝĞƐŵĂǇŶĞĞĚƚŽĐŽŶƐŝĚĞƌƉĂƌƚŝĐŝƉĂŶƚƐ ?ĐŽŵŵŝƚŵĞŶƚĂŶĚ
connection to the SWIFFT study.  
 
Insert Table 2: Revised analytic framework. 
 
3.1.2 Understanding the study. 
Both members of the public and SWIFFT PIs suggested that a lack of understanding about the study, 
both in its relevance and its processes; as well a lack of appreciation of its significance might be 
important factors in individuals dropping out of SWIFFT. Providing information about the study was 
considered an obvious response to this danger and the use of accessible formats (such as newsletters 
and websites) to provide exciting and/or enticing messages was considered important: 
 
  ?if you can share background information about it  ? background to how the study is going so 
ƚŚĂƚ ƚŚĞǇŬŶŽǁƚŚĂƚ ƐŽŵĞƚŚŝŶŐ ŝƐŚĂƉƉĞŶŝŶŐĂŶĚƚŚĞǇ ?ƌĞŶŽƚ ũƵƐƚ ĨŝůůŝŶŐ ŝŶ ƚŚĞƐĞ ĨŽƌŵƐĂŶĚ
ƐŽŵĞďŽĚǇ ?ƐũƵƐƚƐƚŝĐŬŝŶŐƚŚĞŵŝŶĂďŽǆ  ? I think the thing about keeping people informed is 
for me would make it more appealing is not just only having a questionnaire coming through 
ƚŚĞƉŽƐƚďƵƚĂƚƐŽŵĞƉŽŝŶƚĂůĞƚƚĞƌŽƌƐŽŵĞŝŶĨŽƌŵĂƚŝŽŶƐĂǇŝŶŐƚŚŝƐŝƐǁŚĂƚǁĞ ?ǀĞĚŽŶĞƚŚŝƐŝƐ
ǁŚĂƚǁĞ ?ƌĞĚŽŝŶŐ  Wso that you know that somebody is actually looking at these things and 
ƐŽŵĞƚŚŝŶŐ ?ƐďĞŝŶŐĚŽŶĞ ?(Sarah) 
 
 ?They need to appreciate the importance of follow-up and continued engagement with the 
study and the wider implications for managing this in the long term. It may be that they do not 
ĂƉƉƌĞĐŝĂƚĞ ƚŚĞ ĐŽŶƚƌŝďƵƚŝŽŶ ƚŚĞǇ ĂƌĞ ŵĂŬŝŶŐ ĂŶĚ ĨĞĞů ĂƐ ŝŶĚŝǀŝĚƵĂůƐ ƚŽ ďĞ ƵŶŝŵƉŽƌƚĂŶƚ ? ?
(SWIFFT PI 5  W survey response) 
 
 
3.1.3 Valuing the study 
Notes taken during the Research Nurse workshop similarly illustrate the importance of providing 
information to participants. In this session another form of information was also considered 
significant  W  “remember personal information [about the participant], spend time with them make 
ƚŚĞŵĨĞĞůƐƉĞĐŝĂů ? ?ZĞŵĞŵďĞƌƉĞƌƐŽŶĂůĚĞƚĂŝůƐ, communicate well, and thank ƚŚĞŵĞǀĞƌǇƚŝŵĞ ?. 
Demonstrating an interest in the participant and their experience (of fracture, treatment, and 
research) was considered a way of helping a participant feel valued and involved in the study. More 
than this  “on-going personal contact with patients ? ?  “continuity of contact ? ? “being accessible ?ĂŶĚ
 “building relationships ?ǁĞƌĞĐŽŵŵŽŶůǇƉĞƌĐĞŝǀĞĚƚŽĞŶĂďůĞƉĂƌƚŝĐŝƉĂƚŝŽŶĂŶĚĞŶĐŽƵƌĂŐĞƌĞtention.  
 
 “A sense of involvement. Consultant at follow up - not palming it off to juniors. I see all of our 
patients on each follow up and reinforce how important it is ? ?(SWIFFT PI 3  W survey response) 
 
Personalizing involvement in SWIFFT was also advocated by members of the public: 
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 ?making it personal to them is a big thing as well  W making them feel like them in particular, 
they in person are going ƚŽŚĞůƉƐŚĂƉĞƚŚĞƐƚƵĚǇ ? 
 
  ?or they could have their name on the paper [letter] so that when they read it  W ŝƚ ?Ɛjust to 
them as opposed to  ?ĂŶŽŶǇŵŽƵƐĐŽŵŵƵŶŝĐĂƚŝŽŶƐ ? ?ŝƚ ?ƐǁŽƌƚŚĚŽŝŶŐ W its making a difference 
and it needs to be personal ?(James and Matthew in discussion) 
 
 
Other mechanisms for making SWIFFT more personally engaging included generating a competitive 
element to it, including maps which show areas which are recruiting and retaining participants,  “you 
ĐŽƵůĚĚŽŝƚŐĞŽŐƌĂƉŚŝĐĂůůǇůŝŬĞĂŐƌĂƉŚƐĂǇŝŶŐǁŚŽ ?ƐĐŽŶƚƌŝďƵƚĞĚŵŽƐƚ ?ƚŚĞƌĞ ?ƐƚŚĞǁŚŽůĞĐŽƵŶƚƌǇ
pride then isn ?ƚƚŚĞƌĞ ?ŬŝŶĚŽĨDĂŶĐŚĞƐƚĞƌǀƐ>ŝǀĞƌƉŽŽůǀƐ ? ? ?Similarly, a lottery-style prize draw was 
proposed as more exciting than standard inconvenience payments. Discussion of payments was 
otherwise inconclusive with the importance of rewarding participation recognized but the form of 
payment (money, voucher, gift, etc.) and amount and schedule inconclusive. 
 
 ? ? ?ǇĞĂƌƐŽůĚƐĂƌĞŽĨƚĞŶƋƵŝƚĞƐĞůĨ-ĐĞŶƚĞƌĞĚĂŶĚĐĞƌƚĂŝŶůǇĂƌĞƌĞƐŝƐƚĂŶƚƚŽďĞŝŶŐĂĚǀŝƐĞĚ ?ƚŚĞǇ
need to be engaged and they need to see some value for them. Financial incentive is one way, 
ƉĞƌŚĂƉƐĂŶŝƚƵŶĞƐŐŝĨƚĐĂƌĚŽƌĂŐŝĨƚĐĂƌĚĨŽƌĂsŝĨƚŚĞǇĂƚƚĞŶĚƚŚĞŝƌĨŝƌƐƚĨĞǁĂƉƉŽŝŶƚŵĞŶƚƐ ? ?
(SWIFFT PI 9   W survey response) 
 
  ?'iving money might encourage people just to go yeah yeah yeah without really thinking 
ĂďŽƵƚ ŝƚďƵƚƚŚĞƌĞ ?ƐĂŚĞůůŽĨĂ ůŽƚŽĨƉĞŽƉůĞǁŚŽũƵƐƚǁŽƵůĚŶ ?ƚĞǀĞŶƚŽƵĐŚŝƚ ŝĨƚŚĞƌĞǁĂƐŶ ?ƚ
ĂŶǇƚŚŝŶŐŝŶŝƚĨŽƌƚŚĞŵĂŶĚƚŚĂƚ ?ƐǁŚĂƚǁĞ ?ǀĞŐŽƚƚŽƌĞŵĞŵďĞƌƚŚĂƚƚŚĞƌĞŝƐĂůŽƚŽĨƉĞŽƉůĞǁŚŽ
ĂƌĞ ‘ǁŚĂƚ ?ƐŝŶŝƚĨŽƌŵĞ ?ƐŽƚŚĂƚŝƐĂďŝŐĚŝĨĨĞƌĞŶĐĞǇŽƵŬŶŽǁ ? ?40 is a big incentive ? (Peter) 
 
 ?dŚĂƚ ?ƐǁŚĂƚ/ǁĂƐƚŚŝŶŬŝŶŐ ?ǁŚĂƚĂďŽƵƚ ? ? ? ? ? ? ? ?ƚŚĞŶǇŽƵ ?ƌ ĚŽƵďůŝŶŐŝƚĞĂĐŚƚŝŵĞ ? ?(Sarah) 
 
 ?ƚŚĞƌĞ ?ƐŶŽƉŽŝŶƚŐŝǀŝŶŐƚŽŽŵƵĐŚŝŶĐĞŶƚŝǀĞĂƚƚŚĞĞŶĚďĞĐĂƵƐĞǇŽƵ ?ǀĞŐŽƚƚŽŬĞĞƉƚŚĞŵƚŽƚŚĞ
ĞŶĚĂŶĚǇŽƵ ?ǀĞŐŽƚƚŽŬĞĞƉƚŚĞŵfrom the start to the end ?(Amanda)  
 
Research nurses pointed to the danger of participation in SWIFFT being less attractive once a 
participant feels that their fracture has healed. Similar opinions were expressed by the SWIFFT PIs and 
in the public workshop where previous fracture patients indicated a desire to get back to normal as 
ƐŽŽŶĂƐƚŚĞŝƌĐĂƐƚŚĂĚďĞĞŶƌĞŵŽǀĞĚ ?tŝĚĞƌĂƐƐĞƌƚŝŽŶƐŽĨ  ?ďĞŝŶŐƚŽŽďƵƐǇ ?ƌĞŝŶĨŽƌĐĞĚƚŚĞƉŽŝŶƚƚŚĂƚ
long-term commitment might be difficult to achieve with this population of generally active younger 
individuals.  
 
 ?,Ğ ?ƐŐŽƚŶŽĐŽŶĐĞƌŶƐ ?ŚĞ ?ƐǁŽƌŬŝŶŐĨƵůůƚŝŵĞ ?ŚĞƐĂŝĚŚĞ ?ƐĚŽŝŶŐĨŝŶĞŚĞĚŽŶ ?ƚƐĞĞǁŚǇ/ ?d want 
Śŝŵ ƚŽ ĐŽŵĞ ƐŽ ŚĞĐĂŶ ?ƚ ƵŶĚĞƌƐƚĂŶĚ ǁŚǇ ŚĞ ŶĞĞĚƐ ƚŽ ĐŽŵĞ ďĂĐŬďĞĐĂƵƐĞĐůŝŶŝĐĂůůǇ ƚŚĞǇ ?ƌĞ
getting ďĞƚƚĞƌ ? ƚŚĞǇ ?ǀĞ ŐŽƚ Ă ĨƵůů ƌĂŶŐĞ ŽĨ ŵŽǀĞŵĞŶƚ ƚŚĂƚ ?Ɛ ǁŚǇ/ ĐĂŶ ?ƚ ŐĞƚ ƚŚĞŵ ďĂĐŬ ?
[Research Nurse] 
 
 ?yeah  W /ƚŚŝŶŬƚŚĞƌĞ ?ƐĂůŽƚŽĨƉĞŽƉůĞ- it could be an age thing [young] -  but for me, my arm 
was in a cast [when it] came out of the cast and from that seĐŽŶĚŽĨŝƚĐŽŵŝŶŐŽƵƚ/ ?ĚŚĞĂůĞĚ W
/ ?ŵĚŽŶĞŶŽǁ W/ĚŽŶ ?ƚŶĞĞĚƚŽŐŽďĂĐŬƚŽƚŚĞŚŽƐƉŝƚĂů ?ƚŚĞŽŶůǇǁĂǇǇŽƵ ?ƌĞŐŽŶŶĂŐĞƚƉĞŽƉůĞ
ŝŶŝƐďǇƐĂǇŝŶŐŚĞƌĞ ?ƐƐŽŵĞŵŽŶĞǇ ?ǇŽƵĂƐŬĞĚŝĨŵǇĨƌŝĞŶĚƐǁŽƵůĚĚŽŝƚ ?ƚŚĞǇǁŽƵůĚŶ ?ƚĐŽŵĞ
ďĂĐŬ ? (James) 
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 ?The patient who failed to attend three times for follow up was 18 years old. She is young, 
unreliable and enjoys partying and occasionally studies. She forgot the first time, the second 
time she couldn't be bothered as her wrist was not painful and did not see any gain for her to 
ƌĞƚƵƌŶ ?tĞƉĞƌƐƵĂĚĞĚŚĞƌƚŽĐŽŵĞďĂĐŬĂƚĂŶŽƚŚĞƌĐůŝŶŝĐďƵƚŚĂĚƚŽƌĞŵŝŶĚŚĞƌŽŶƚŚĞĚĂǇ ? ?
(SWIFFT PI 9   W survey response) 
 
 
 
 
3.2 Trial management strategies & routine trial data monitoring. 
Informed by this stakeholder consultation SWIFFT study processes have been developed in a number 
of ways that are designed to support improved participant retention. 
 
Early adopted strategies have included: the collection of questionnaire data at hospital clinic 
appointments (in addition to their postal administration); the co-ordination of research appointments 
at the same time as clinic appointments; participants primed by being shown follow-up 
questionnaires at recruitment; and, on-going review of open-response comments recorded by 
patients on questionnaires. 
 
Later measures that have been implemented include: the creation of a regular participant-targeted 
newsletter; the creation of a participant-targeted website which includes information about study 
progress (http://www.swifft.co.uk/); the creation of a patient video to provide information in a more 
user friendly fashion about why patients should continue to stay in the study, the video takes the 
form of a question and answer discussion with the SWIFFT PPI representative and is available on the 
website ?ƚŚĞĐƌĞĂƚŝŽŶŽĨĂƐƚƵĚǇƚĂŐůŝŶĞ ? “^t/&&dƐƚƵĚǇ PƉĂƚŝĞŶƚƐŚĞůƉŝŶŐƚŽŝŵƉƌŽǀĞŚĞĂůƚŚĐĂƌĞ
through research ?, which is affixed as a label to all participant correspondence; and finally, instigating 
Ă “^t/&&d/-ƉĂĚ>ŽƚƚĞƌǇ ?ǁŚĞƌĞĂůůƉĂƌƚŝĐŝƉants who complete data collection are entered into a series 
of prize drawers (at 26 weeks, 52 weeks and 5 years). 
 
A number of additional strategies proposed in the stakeholder consultation have been considered and 
rejected, these include: online data collection of questionnaire instruments; abandoning the SF-12 to 
reduce data collection burden; and, amending the participant payment schedule to increase the 
payment at 26 weeks. 
 
4. Discussion. 
 
Previous research has been inconclusive about how best to respond to difficulties in trial retention; 
multiple strategies have been offered but few are supported by a strong evidence base (14). The 
stakeholder driven approach that we employed is informed by this uncertainty and by a body of 
literature which points to the value of trial specific insight and strategies (11, 14, 16). Whilst the 
11 
 
insights discussed here were in the context of a surgical trial with a predominantly male and younger 
population, they could be potentially considered for trials in general.  
 
4.1 General insight. 
4.1.1 Stakeholder consultation to inform retention strategies.   
Our consultative process offers a map for engagement and a model for handling data that others 
concerned about trial retention may wish to replicate.  
 
We have demonstrated the value of a broader consultative net than concerns for public and patient 
involvement might normally advocate (20). Here we consulted with stakeholders from within our trial 
(local investigators and research nurses), from those outside of the trial (in our public workshop), and 
routinely incorporated this feedback into trial management systems that involved the TSC, DMEC and 
TMG. This combination of multiple perspectives and mechanisms has informed strategies to improve 
retention that are both meaningful to participants and practical within the conduct of the trial. 
 
We have also, in handling the stakeholder data, made a strong analytic distinction between practical 
challenges, practical solutions, and additional (notional) benefits. This tripartite model, in part, 
reflects the nature of the SWIFFT trial population, but it also reflects the broadly held notion that 
some participants may simply lose interest in a study (14). The danger that trial participants may 
simply lose interest will vary by trial (where target population, trial duration and participant burden 
are likely to be factors), but we would argue that all triallists should be wary of this. Looking beyond 
the practical challenge of attending an appointment or completing a research instrument is 
consequently an important (although possibly less obvious) focus for stakeholder consultation and for 
those strategies generated to support retention.  
 
Whilst our approach elicited and incorporated views from a variety of stakeholders, this did not 
include the perspective of trial participants themselves. We have, however, also been interviewing 
patients who took part in the SWIFFT trial and individuals who did not. We expect these interview 
data will help to generate further insights into the experiences and attitudes of patients towards 
surgical, clinic al research which may include how to enhance retention of trial participants (35).  
 
4.1.2 Integrating consultation into trial operation & management strategies. 
Stakeholder consultative processes like those described above risk being tokenistic if they are not 
fully integrated into both the conduct of a trial and its management systems and processes.  
 
We would suggest that a concern for participant retention should be manifest from the earliest 
possible point, and here we initiated participant priming about the schedule of return visits and about 
other data collection during the recruitment process. Whilst this might feel like an added barrier to 
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recruitment it is pertinent to reflect that if a concern for retention only emerges when participants 
are not attending appointments (or returning instruments) then it may already be too late to remedy 
any difficulties. 
 
We would also remind that retention should be fully integrated into trial management processes. 
Here we included both recruitment and retention as separate standing items on all meeting agendas 
so that specific attention is given to retention. The stakeholder consultation activities were presented 
as a part of these meetings (at the TMG in particular) and strategies for amending research processes 
in order to improve retention developed (in the TMG) and approved (in the TSC). More than this, 
monitoring retention and data completeness has been given equal weight alongside monitoring of 
recruitment statistics. Our general point remains that retention is as important as recruitment for 
clinical trials. 
 
4.2 Specific insight.  
4.2.1 Difficulties of retention in the SWIFFT population.  
Our stakeholder consultation has demonstrated that many of the general points about trial retention 
are pertinent to our younger, trauma related research population. Moreover they point to some very 
specific selective attrition associated with a younger, active population. That such participants might 
be difficult to track due to changes to contact details was presented as normal and almost 
unavoidable in this group where frequent changes to electronic and mobile telephone contact details 
are common. That this population might be easily distracted and in transition in other parts of their 
lives (leaving home, entering work, entering university, etc.) were also perceived to exaggerate 
retention issues. That this population might also be more active in lifestyle and consequently 
impatient to regain normality once their injury has healed further contributes to the danger that they 
will lose interest and drop-out of longer term follow-up. 
 
4.2.2 Solutions to retention difficulties in the SWIFFT population 
Given these specific challenges our stakeholder consultation has generated a number of strategies 
which are concerned with communication and engaging this young, active population; some of these 
strategies are evident in the existing literature, some are new and novel. 
 
Elsewhere studies have pointed to improved communication with participants as benefiting trial 
recruitment (3, 12); here a SWIFFT newsletter, website and patient video have been created to inform 
participants about study progress and processes. These mechanisms are designed to act both as a 
reminder about the study as well as containing information and messages which will generate 
enthusiasm. The study tagline is similarly intended to reinforce the purpose and importance of the 
research in a similar way that teasers on envelopes might offer benefit (15).  
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More distinctively our consultative process has generated suggestions that a prize-draw / lottery 
might be a more exciting mechanism for reimbursing participants for their inconvenience, and that 
friendly Research Nurses might generate a more enduring relationship with study participants. These 
strategies speak directly to a younger, more easily distracted study population. That friendly nurses 
might not formally be implemented is less significant than the insight it offers about the clinical 
population and how best to motivate their continued involvement.  
 
In response to concerns about a research population which is active (in employment, study, lifestyle) 
and which might find multiple face-to-face appointments practically difficult to attend (and difficult to 
justify) our stakeholders proposed the coordination of clinical and research appointments, they also 
suggested greater flexibility in appointment timing and location which have both been implemented 
when possible.  
 
Other strategies suggested in the literature have not been adopted for a variety of reasons such as 
shorter research instruments (8, 15), open trial design and opt-in trial design (5) and on-line data 
collection (14). It is possible that undertaking this consultation at an earlier stage (during a pilot study 
perhaps) might have informed more fundamental trial design amendments that have not been 
possible here. 
 
Finally there is increasing awareness for the need to provide an evidence-base to address the 
uncertainties around the effective and efficient conduct of trials. Embedded methodological studies 
within a trial (SWAT) have been proposed to identify strategies that will improve recruitment and 
retention of participants in trials (40). The Northern Ireland Hub for Trials Methodology Research has 
ĐƌĞĂƚĞĚĂƌĞƉŽƐŝƚŽƌǇƚŚĂƚĐƵƌƌĞŶƚůǇůŝƐƚƐ ? ?ƉƌŽƚŽĐŽůƐĨŽƌ^td ?ƐƚŚĂƚŝŶĐůƵĚĞƐŝŶƚĞƌǀĞŶƚŝŽŶƐƚŽ
improve retention such as timing and mode of delivery of self-competed questionnaires, 
questionnaire design, use of financial incentives, electronic prompts, newsletters and many more. 
^ƚƌĂƚĞŐŝĞƐŝĚĞŶƚŝĨŝĞĚĨƌŽŵŽƵƌƐƚĂŬĞŚŽůĚĞƌĐŽŶƐƵůƚĂƚŝŽŶƐĐŽƵůĚďĞĞǀĂůƵĂƚĞĚĂƐƚŚĞƐĞ^td ?Ɛ ? 
 
5. Conclusion.  
 
Participant retention is a key factor in the success of any research study; it is also a complex matter 
which defies general assessment and single, simple strategies. This commentary reports upon a 
consultative exercise intended to generate strategies to support retention in a surgical, clinical trial. It 
draws upon the views of three distinct stakeholder groups (patients, research nurses and consultant 
clinicians) and suggests that motivational factors about the patient understanding and valuing of the 
study, such as newsletters, websites, patient video, are as important as practical measures such as 
collecting questionnaires in clinic and being flexible with the arrangement of appointments.  
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The participatory approach adopted offers benefit both in identifying strategies for amending trial 
processes, but also in engaging directly those who will be most affected by such changes (RN and 
consultants). It is limited by the inclusion of a relatively small number of stakeholders and by the 
limited amount of time taken to consult with them  W more stakeholder events might generate further 
and more detailed insight. Given our target clinical population (younger) we might have thought more 
about social media and other electronic forms of consultation and contact. In a similar vein for more 
complex trials (with more varied populations, or incorporating more complex interventions) it may be 
that different types of stakeholder consultation might be required  W reaching more broadly, 
generating multiple and varied forms of consultation. That our public stakeholders here are self-
selected, and perhaps atypical in their willingness to support research management processes, also 
points to a need for broader and more extensive stakeholder consultation in this area. 
 
 Finally, it is too complex to examine which of the multiple strategies that were implemented in 
SWIFFT affected retention. Where possible, randomised evaluations embedded within host clinical 
trials to evaluate strategies identified here is recommended. 
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Table 1: Initial analytic template. 
THEME Higher level coding 
 
Lower level coding. 
Barriers to Participation. 
 
[53 data points] 
Barriers to completing 
survey 
o Unnecessary questions. 
o Survey too long. 
o Other barriers to survey. 
 
 Barriers to follow-up 
appointment 
o Time commitment. 
 
 Perceptions of the study 
which might be a barrier 
o Relationship to clinical care. 
o Reverse psychology 
 
 Other uncategorised barriers o Personal/personality factors. 
o Social/familial barriers. 
 
Notional strategies to 
support involvement 
 
[47 data points] 
Focus upon study detail. o Emphasize significance of the 
study. 
o Provision of information. 
 
 Focus upon the person. o Patient advocate for the study. 
o Personalise study. 
o The study values your 
participation. 
 
 Other uncategorised 
strategies 
 
Practical strategies to 
support involvement. 
 
[93 data points] 
Practical support for follow-
up. 
o Convenience of appointments. 
o Money as an incentive. 
o Non-money incentives. 
o SMS as reminder. 
o Vouchers as incentives. 
 
 Practical support for 
questionnaire. 
o Collect in clinic. 
o Online or other mechanisms. 
 
 Practical support for study 
engagement. 
o Individual personal contact 
details. 
o Study newsletter.  
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Table 2: Revised analytic framework. 
 
1. Practical challenges: 
 
Practical solutions: 
 
other benefits: 
 
 
Survey instrument 
looks long and 
intimidating. 
 
 
 
A. Reduce/reformat survey, 
possibly for online delivery. 
 
B. Collect survey data at clinic 
appointments. 
 
C. Make follow-up appointments 
more convenient [not 9-5, not 
hospital]. 
 
D. Reminders about on-going 
participation. 
 
 
 
 
 
1. Multiple mechanisms for 
completing surveys will reinforce 
that participation is important and 
valued. 
 
2. Flexibility and responsiveness 
with appointment time/location 
will reinforce that participation is 
important and valued. 
 
 
 
Follow-up 
appointments are 
inconvenient and time 
consuming. 
 
 
Economic and/or 
familial circumstances 
might get in the way. 
 
 
2. Understanding the 
study: 
 
Practical solutions: 
 
other benefits: 
 
Not recognising the 
impact that the research 
might make. 
 
 
 
A. A dedicated newsletter which 
provides detailed information 
about the study and its progress. 
 
B. A dedicated website which 
provides detailed information 
about the study and its progress. 
  
   
  ?Ǥ		ǯǡ
significance and potential.  
 
2. Demonstrate on-going progress 
in study milestones and 
achievements. 
 
3. Provide detail about the study 
and its processes Ȃ about why 
elements are necessary 
 
Not appreciating that 
the study is making 
progress. 
 
 
3. Valuing the study: 
 
Practical solutions: 
 
other benefits: 
 
 
 
 ǲǯǳ
benefit do I gain from 
taking part? 
 
 
A. Personalised communications 
help to build connection to the 
study. 
 
B. A consistent, named contact 
helps to build connection to the 
study. 
 ǤǮǯ
competition Ȃ e.g. recruitment 
and retention rates by 
region/hospital. 
 
D. Personal testimonies from 
patients reinforcing benefit of 
being involved. 
 
 
1. Generate attachment to the 
study beyond personal, clinical 
care. 
 
2. Emphasise that participation is 
meaningful and valued. 
 
3. Enable participants to position 
themselves with regard the whole 
study, i.e. how many other people, 
how many locally, how many at 6 
months, etc.   
 
4. Ensure that no-one is out of 
pocket. 
 
5. Provide a variety of incentives 
to maintain involvement Ȃ money, ǮǯǡǮǯǤ 
 
 
Money might help 
retention in some cases, 
but not all (esp, small 
amounts). 
 
 
 
